Elizabeth Buck founded Black Diamond Therapeutics, Inc. Currently, she is CSO, EVP-Discovery & Translational Sciences at this company.

In her past career she held the position of Chief Scientific Officer-Therapeutics at MetaStat, Inc. and Assistant Director-Advanced Preclinical at OSI Pharmaceuticals, Inc.

She received an undergraduate degree from the University of New Hampshire and a doctorate from Icah School of Medicine at Mount Sinai.